Daridorexant 50 mg
Daridorexant 50 mg is a pharmaceutical drug with 13 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
4
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Daridorexant for Alcohol Use Disorder
Dual Orexin Antagonism and Emotion and Affective Processing Study
Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
Clinical Trials (13)
Efficacy and Safety of Daridorexant in Patients With Major Depressive Disorder and Insomnia
Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease
Daridorexant for Alcohol Use Disorder
Dual Orexin Antagonism and Emotion and Affective Processing Study
Dose-finding Study Assessing the Efficacy, Safety, and Pharmacokinetics of Daridorexant in Subjects Aged 10 to < 18 Years With Insomnia Disorder
Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking
Daridorexant to Prevent Post-cardiotomy Delirium
Daridorexant for Alzheimer Disease Prevention
Daridorexant to Prevent Delirium After Heart Surgery
Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia with Daridorexant in Canada
A Study of the Effect of Daridorexant on Nighttime Body Posture, the Noise Level Required to Wake up, and the Ability to Remember Words Previously Presented
Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder
Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13